|
Volumn 19, Issue 17-19, 2001, Pages 2221-2226
|
Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults
|
Author keywords
Children; Influenza; Vaccine
|
Indexed keywords
ANTIBIOTIC AGENT;
INFLUENZA VACCINE;
LIVE VACCINE;
NON PRESCRIPTION DRUG;
TRIPLE VACCINE;
ADULT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CONTROL;
DISEASE DURATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEVER;
HEALTH CARE PERSONNEL;
HEALTH CARE UTILIZATION;
HIGH RISK POPULATION;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
LOWER RESPIRATORY TRACT INFECTION;
MALE;
MULTICENTER STUDY;
NORMAL HUMAN;
OTITIS MEDIA;
PRESCHOOL CHILD;
PRESCRIPTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
UPPER RESPIRATORY TRACT INFECTION;
WORK;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CHILD, PRESCHOOL;
DOUBLE-BLIND METHOD;
HUMANS;
INFANT;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MIDDLE AGED;
SAFETY;
|
EID: 0035925590
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(00)00449-7 Document Type: Conference Paper |
Times cited : (83)
|
References (14)
|